erythropoietic protoporphyria

FDA approves Clinuvel drug for rare disease causing pain on exposure to sunlight

The agency approved Scenesse, a subcutaneous implant for treating the rare disorder erythropoietic protoporphyria. The drug is the first FDA-approved treatment for EPP.